BROMANYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bromanyl, and when can generic versions of Bromanyl launch?
Bromanyl is a drug marketed by Alpharma Us Pharms and is included in one NDA.
The generic ingredient in BROMANYL is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
Summary for BROMANYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 508 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BROMANYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BROMANYL
US Patents and Regulatory Information for BROMANYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | BROMANYL | bromodiphenhydramine hydrochloride; codeine phosphate | SYRUP;ORAL | 088343-001 | Aug 15, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |